Science journalism by Leonid Schneider, on research integrity and academic publishing in life sciences and biomedicine
Plan S, designed by the former EU Commissioner Robert-Jan Smits, became a complete and chaotic mess where everyone, including the members of the signatory cOAlition S of research founders, does whatever they want. I learned all that while participating at the Academic Publishing Europe (APE) conference in Berlin, on 15-16 January.
Professor Ruben Plentz chose to focus his career on clinical medicine in Bremen, despite his tremendous academic achievements in cancer research. Was it because malicious critics harassed him with frivolous investigations and corrections, envious at all those peer-reviewed cancer cures the great doctor invented?
Research by German journalists revealed whole lists of German academics engaging in predatory publishing and scamferences. Named on over 60 predatory conference papers is Bernd Scholz-Reiter, Rector of the University of Bremen and former Vice-President of DFG. Several such papers are even self-plagiarised, and were used in DFG project reports and Scholz-Reiter’s rectorship application from 2011
This is a story of a plant scientist in France, Steffen Reinbothe. He and his sister Christiane used to hold academic positions in Germany, but now they both returned to France, to Grenoble. The move might have had to do with a dossier from 2009, made by a former lab member and circulated among peers.
Whatever concerns any peers might have had: Steffen and Christiane Reinbothe could rely on the “contributed” track at PNAS.
I finally succeeded to interview the only woman among Human Brain Project leaders, the scientific director Katrin Amunts. In my previous article, I published a non-interview, using bits from HBP website as stand-in for her answers. Now, in this long read, Professor Amunts provided me with her replies.
I was keen to interview the only woman among Human Brain Project leaders, the scientific director Katrin Amunts. In November 2017, she agreed to do an interview by email. In March 2018, Amunts announced that “the manuscript already has a veritable size of several pages”. She never contacted me since. This is therefore a non-interview.
German Research Foundation (DFG) terminated the investigation against their Senator and Marburg University professor Roland Lill, after having found no research misconduct. No comments are issued on the integrity of the data in his papers on yeast biochemistry, or on some unusual image manipulations which were already admitted by Lill and his former PhD students
In the aftermath of the scandal around Paolo Macchiarini, which left many patients dead, his former employer Karolinska Institutet requested a retraction a paper. The Swiss-German medical publisher Karger and its journal Respiration however categorically refused and ordered KI not “to patronize the readers of the journal ‘Respiration’.” The German Editor-in-Chief had namely a huge conflict of interest.
The German justice has spoken on trachea transplants again, in the appeal hearing at Kammergericht Berlin, and found the problemContinue Reading
German diabetologist Kathrin Maedler is a central figure of a questionable academic dynasty. Using Photoshop simulations, she discovered a cure for diabetes, which was then allegedly validated in clinical trials led by her Swiss PhD advisor Marc Donath. 15 years later, the Maedler-Donath diabetes cure was proven as utterly ineffective by same Donath, in another clinical trial. Maedler’s own PhD student, Amin Ardestani is group leader in Bremen, despite data irregularities and unacknowledged textual reuse in his thesis.
